With a market cap. of $25.4 billion, Houston, Texas-based CenterPoint Energy, Inc. (CNP) is an energy delivery company providing electric and natural gas services across Indiana, Minnesota, Ohio, and Texas. The company serves more than 7 million metered customers through its electric transmission and distribution, power generation, and natural gas distribution operations.
Companies valued between $10 billion and $200 billion are generally classified as “large-cap stocks,” and CenterPoint Energy comfortably fits this category. As of June 30, 2026, CenterPoint Energy owned approximately $48.3 billion in assets and employed around 8,800 people, with a history spanning more than 150 years.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
CNP stock has slipped 15.3% from its 52-week high of $45.26, reached on Jul. 28. Over the past three months, CNP shares have dipped 10.5%, underperforming the Nasdaq Composite ( $NASX), which has declined marginally over the same period.
CNP stock is down marginally on a YTD basis, lagging behind NASX’s 13.6% gain. Moreover, shares of the company have risen marginally over the past 52 weeks, compared to NASX’s 17.5% return over the same time frame.
The stock has been trading below its 50-day and 200-day moving averages since August.
CenterPoint Energy has underperformed due to its substantial capital requirements and reliance on external financing, which may increase dilution risk. The company also faces pressure from its relatively low dividend yield, elevated valuation, and the need to convert expected data-center and large-load electricity demand into contracted, rate-base-producing assets.
In comparison, rival Duke Energy Corporation (DUK) has declined 2.6% over the past 52 weeks, lagging behind CNP stock over the same period.
Despite the stock’s underperformance relative to the NASX, analysts remain moderately optimistic on CNP. The stock has a consensus rating of “Moderate Buy” from 19 analysts in coverage, and the mean price target of $45.29 implies 17.5% upside from its current price.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
XENE Stock Plummets as Xenon Pharmaceuticals Pauses Drug Trial Tower Semiconductor Just Scored a New Bullish Rating. What to Know. The U.S. Government Is Preparing to Offload Over 9 Million GlobalFoundries Shares. How You Should Play GFS Stock in Response. Wells Fargo Just Downgraded Netflix Stock. Here's Why.